Verition Fund Management
Overview
Verition Fund Management is a multi-strategy, multi-manager hedge fund that focuses on global investment strategies including Credit, Fixed Income & Macro, Convertible & Volatility Arbitrage, Event-Driven, Equity Long/Short & Capital Markets, and Quantitative Strategies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Evommune | Oct 2024 | Series C | Co-investor |
| Frequency Therapeutics | Nov 2023 | Private Placement | Co-investor |
| Georgiamune | Aug 2023 | Series A | Co-investor |
| Evommune | Jun 2023 | Series B | Lead |
| Evommune | Mar 2023 | Series B | Co-investor |
Key People
Josh Goldstein
Principal, President And Chief Operating Officer
Alvaro Mucida
Portfolio Manager
Andrew Burton
Portfolio Manager
Ashar Khan
Portfolio Manager
Benjamin Wanger
Portfolio Manager
Brad Schwer
Portfolio Manager
Carl Y.
Portfolio Manager
Chen Ling
Portfolio Manager
Chris Daniel
Portfolio Manager
Chris Marcellin
Portfolio Manager
Daniel Docherty
Portfolio Manager
Douglas Viloria
Portfolio Manager
Eli Benson
Portfolio Manager
Eric Harwood
Portfolio Manager
Eric Rogers
Portfolio Manager
Eugene Nagirner
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
